Novo Nordisk

Page 2 of 9

LArs Freurgaard Jorgensen and Ursula von der Leyen pictured among Danish business leaders in 2024.
Health

Europe’s pharma titans confront von der Leyen with threat to yank $113 billion from EU and relocate to U.S. as Trump plans ‘major’ tariffs

By
April 9, 2025
Ozempic and Wegovy pumped $26 billion into Novo Nordisk last year. Can the pharma giant find its next breakthrough before the boom ends?
Magazine

Ozempic and Wegovy pumped $26 billion into Novo Nordisk last year. Can the pharma giant find its next breakthrough before the boom ends?

By
March 31, 2025
SAP topples Novo to become Europe’s most-valuable listed company
Finance

SAP topples Novo to become Europe’s most-valuable listed company

By Henry Ren and Bloomberg
March 24, 2025
Roche, Zealand Pharma in $5.3 billion pact for obesity drugs
Retail

Roche, Zealand Pharma in $5.3 billion pact for obesity drugs

By Paula Doenecke, Naomi Kresge and Bloomberg
March 12, 2025
Novo Nordisk CEO warns tariffs could send the prices of Ozempic and Wegovy higher
Finance

Novo Nordisk CEO warns tariffs could send the prices of Ozempic and Wegovy higher

By
March 7, 2025
Semaglutide medications Wegovy and Ozempic are pictured
Health

Wegovy, Ozempic shortage declared over, hitting copycats like Hims & Hers

By Bloomberg, Madison Muller, Ike Swetlitz and Naomi Kresge
February 21, 2025
A woman injects herself with medication.
Health

Ozempic, Wegovy maker calls out Hims & Hers Super Bowl ad: ‘Check before you inject’

By
February 11, 2025
Novo Nordisk President and CEO Lars Fruergaard Jorgensen testifies before the Senate Health, Education, Labor, and Pensions Committee in the Dirksen Senate Office Building on Capitol Hill on September 24, 2024 in Washington, DC. The committee heard testimony from Jorgensen about the price of popular pharmaceuticals made by Novo Nordisk that help treat diabetes and obesity, including Wegovy and Ozempic.
Leadership

As U.S. firms scrap diversity targets, the CEO behind Ozempic and Wegovy took a pay cut for missing them

By
February 5, 2025
Karsten Munk Knudsen, chief financial officer of Novo Nordisk A/S, at the company's headquarters in Bagsvaerd, Denmark, on Tuesday, Nov. 26, 2024.
Health

As growth slows, CFO says Novo Nordisk is prepping for the next generation of weight loss drugs

By
February 5, 2025
Novo Nordisk advertising logo on facade building, Danish pharmaceutical healthcare giant Novo Nordisk AS, production innovative drugs, obesity treatment Ozempic, Mainz, Germany June 15, 2024
Health

Investors are growing anxious about Novo Nordisk’s silence since disappointing CagriSema weight loss drug results

By
February 4, 2025
A person stands on a scale.
Health

Hims & Hers Super Bowl ad slams pricey pharma industry—and fumbles FDA warnings on compounded GLP-1 drugs

By
February 3, 2025
DeepSeek and Ozempic are complicating decarbonization forecasts
Environment

DeepSeek and Ozempic are complicating decarbonization forecasts

By Aaron Clark and Bloomberg
January 31, 2025
A cautionary tale that Europe can’t afford to ignore
Magazine

A cautionary tale that Europe can’t afford to ignore

By
January 31, 2025
The increase in online searches for obesity management drugs in recent years correlated to a surge in dispensed prescriptions, according to a new study from the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease.
Health

Online searches predicted the surge in prescriptions of weight-loss drugs like Wegovy and Zepbound, study says. Here’s what could happen next

By
January 29, 2025
A person, with only the midsection visible, injects Wegovy under the skin of their stomach.
Finance

Novo Nordisk stock surges 7% after Ozempic maker’s latest weight-loss drug shows promise

By
January 24, 2025

Most Popular